There is a positive correlation between NLRC5 and VEGF-A expression, which also coordinates the activation of the PI3K/AKT signaling pathway (55), demonstrating that NLRC5 promotes HCC progression via the AKT/VEGF-A signaling pathway (Figure 3). The gene discussed is AKT1; the disease is hepatocellular carcinoma.